SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (1503)2/4/2002 5:21:22 PM
From: Madharry  Respond to of 10345
 
TY so this means that after the company's previously lengthy response assuring investors that all its was properly disclosed it now turns out that in reality there is another $1billion or so of debt that most non irish investors are not aware of. Based on everything that has happened i doubt any funds are going to hold this one by 3/31/02. This is very unfortunate. Between VRTX CBST IMCL and now ELN. you would think biotech would be due for some good news



To: nigel bates who wrote (1503)2/4/2002 5:28:12 PM
From: IRWIN JAMES FRANKEL  Read Replies (1) | Respond to of 10345
 
Thanks Nigel,

That is very interesting. It raises a couple of questions that I do not understand.

Comparing 2001 "As Reported" to "Pro-Forma":

- Total indebtedness rises 1,000.0 [odd that this is even to 5 significant digits]
- Total assets rise 780.3

Total assets rising less that total debts seems odd considering the statement at the end, "As of December 31, 2001 the market value of investments held by the QSPEs would have been sufficient to repay the indebtedness at that date ..."

Anyone understand this?

ij



To: nigel bates who wrote (1503)2/4/2002 7:08:19 PM
From: keokalani'nui  Respond to of 10345
 
>>the market value of investments held by the QSPEs would have been sufficient to repay the indebtedness at that date<<

Wonder what investments those are...hopefully not eln stock.

Wilder